Theralase Technologies Stock Today
| TLT Stock | CAD 0.17 0.01 6.25% |
Performance3 of 100
| Odds Of DistressLess than 19
|
Theralase Technologies is selling for under 0.17 as of the 25th of April 2024; that is 6.25 percent increase since the beginning of the trading day. The stock's lowest day price was 0.16. Theralase Technologies has less than a 19 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Theralase Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of November 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. The company has 235.13 M outstanding shares of which 66.02 K shares are at this time shorted by private and institutional investors with about 0.32 days to cover all short positions. More on Theralase Technologies
Moving against Theralase Stock
| 0.75 | GOOG | Alphabet CDR | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Theralase Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Theralase Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Theralase Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO, Director | Roger DumoulinWhite | ||||
| Thematic Idea | IT (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, IT, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare, Computing (View all Sectors) | ||||
Theralase Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Theralase Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Theralase Technologies' financial leverage. It provides some insight into what part of Theralase Technologies' total assets is financed by creditors.
| |||||
Theralase Technologies (TLT) is traded on TSX Venture Exchange in Canada and employs 12 people. Theralase Technologies is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 38.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Theralase Technologies's market, we take the total number of its shares issued and multiply it by Theralase Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Theralase Technologies classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 235.13 M outstanding shares of which 66.02 K shares are at this time shorted by private and institutional investors with about 0.32 days to cover all short positions.
Theralase Technologies has accumulated about 1.67 M in cash with (4.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Theralase Technologies Probability Of Bankruptcy
Ownership AllocationTheralase Technologies maintains a total of 235.13 Million outstanding shares. Theralase Technologies has 8.1 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Theralase Ownership Details
Theralase Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of Theralase Technologies jumping above the current price in 90 days from now is about 82.5%. The Theralase Technologies probability density function shows the probability of Theralase Technologies stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon the stock has a beta coefficient of 1.8796. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Theralase Technologies will likely underperform. Additionally, theralase Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Theralase Technologies to move above the current price in 90 days from now is about 82.5 (This Theralase Technologies probability density function shows the probability of Theralase Stock to fall within a particular range of prices over 90 days) .
Theralase Technologies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Theralase Technologies market risk premium is the additional return an investor will receive from holding Theralase Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Theralase Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Theralase Technologies' alpha and beta are two of the key measurements used to evaluate Theralase Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 4.12 | |||
| Semi Deviation | 4.29 | |||
| Standard Deviation | 5.77 | |||
| Variance | 33.29 |
Theralase Stock Against Markets
Picking the right benchmark for Theralase Technologies stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Theralase Technologies stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Theralase Technologies is critical whether you are bullish or bearish towards Theralase Technologies at a given time. Please also check how Theralase Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Theralase Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Theralase Technologies Corporate Directors
Theralase Technologies corporate directors refer to members of a Theralase Technologies board of directors. The board of directors generally takes responsibility for the Theralase Technologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Theralase Technologies' board members must vote for the resolution. The Theralase Technologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Randall Bruder | Independent Director | Profile | |
| Guy Anderson | Independent Director | Profile | |
| Michael Borovec | Director of Investor Relations | Profile | |
| Matthew Perraton | Director | Profile |
How to buy Theralase Stock?
Before investing in Theralase Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Theralase Technologies. To buy Theralase Technologies stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Theralase Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Theralase Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Theralase Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Theralase Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Theralase Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Theralase Technologies?
The danger of trading Theralase Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Theralase Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Theralase Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Theralase Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Theralase Stock analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |